SESTD1

SESTD1 is a Ca2+-dependent phospholipid-binding scaffold protein that couples membrane lipid signaling to cytoskeletal regulation and Rho-family GTPase control across ion channel, developmental, and synaptic contexts (PMID:20164195, PMID:23696638, PMID:29293918). Through its SEC14-like lipid-binding domain and spectrin-type cytoskeleton interaction domains, it binds multiple phospholipid species in a Ca2+-dependent manner and associates with the CIRB domain of TRPC4 and TRPC5 channels, where it is required for efficient receptor-mediated TRPC5 activation (PMID:20164195). In the Wnt/Planar Cell Polarity pathway, SESTD1 binds Vangl2 and Dact1 and, through the Dact1 interaction, activates Rho GTPases; mouse knockout phenocopies Dact1 loss with neural tube and tail defects and shows genetic interactions with Vangl2 and Dvl2, the latter potentiating Rho activation by the Dact1–Sestd1 complex (PMID:23696638, PMID:24505507). In neurons, SESTD1 acts as a brake on excitatory connectivity: its SPEC1 domain binds Rac1 and interferes with the Rac1–Trio8 GEF interaction to limit dendritic spine density and mEPSC frequency (PMID:26272757), and loss of Sestd1 in mice reduces dendrite arbors, spines, and excitatory synapses with elevated Rac1 and RhoA activation, in part via complex formation with the Rho-GAP BCR (PMID:29293918). SESTD1 is also required for efficient West Nile virus (Kunjin) replication in human cells and is targeted by the antiviral miRNA miR-532-5p (PMID:26676784).

1. 2010 High

   Established SESTD1 as a TRPC4/TRPC5 channel-associated, Ca2+-dependent lipid-binding protein, defining its core biochemical identity and a functional role in channel activation.

   Evidence Yeast two-hybrid screen, reciprocal Co-IP, in vitro phospholipid-binding assays, domain mapping, and electrophysiology in heterologous cells

   PMID:20164195

   Open questions at the time

   • Lipid-binding specificity in vivo not resolved
   • No structural model of the SEC14-like or spectrin domains
   • Whether lipid binding gates TRPC5 regulation directly was not dissected
2. 2013 High

   Placed Sestd1 in the Wnt/PCP pathway as a Vangl2- and Dact1-binding partner that activates Rho GTPases, connecting it to morphogenetic signaling.

   Evidence Reciprocal Co-IP, domain mapping, mouse knockout phenotyping, genetic epistasis with a Vangl2 semidominant allele, and cell-based Rho GTPase assays

   PMID:23696638

   Open questions at the time

   • Molecular mechanism by which the Dact1–Sestd1 interface activates Rho not defined
   • Direct GEF/GAP not identified in this context
   • Whether lipid binding contributes to PCP function untested
3. 2013 Medium

   Distinguished a Dvl2 branch from the Dact1 axis, showing Dvl2 potentiates Rho activation by the Dact1–Sestd1 complex without affecting β-catenin signaling, and revealing genetic synergy.

   Evidence Co-IP, cell-based β-catenin and Rho GTPase reporter assays, and mouse double-knockout genetic interaction analysis

   PMID:24505507

   Open questions at the time

   • Single-lab study
   • Biochemical basis of Dvl2-enhanced Rho activation unresolved
   • Compartment where the complexes form not defined
4. 2015 High

   Defined a synaptic mechanism in which SESTD1 limits spine density by disrupting the Rac1–Trio8 GEF interaction, identifying the SPEC1 domain as the Rac1-binding module.

   Evidence Overexpression and siRNA knockdown in hippocampal neurons, Co-IP, SPEC1 domain mapping, mEPSC recording, and Trio8-GEF rescue

   PMID:26272757

   Open questions at the time

   • How SESTD1 physically blocks Rac1–Trio8 not structurally defined
   • Link to lipid-binding or channel functions untested
   • In vivo confirmation pending in this study
5. 2015 Medium

   Identified SESTD1 as a host factor required for efficient West Nile virus replication and a target of antiviral miR-532-5p, extending its roles to virus–host interaction.

   Evidence siRNA knockdown with viral replication assay, miRNA target validation, and mouse brain expression analysis

   PMID:26676784

   Open questions at the time

   • Mechanism by which SESTD1 supports replication unknown
   • Single-lab study
   • Whether lipid binding or Rho regulation underlies the viral phenotype untested
6. 2019 High

   Established Sestd1 as a developmentally regulated synaptic protein whose loss reduces dendrite and synapse formation via dysregulated Rho-family GTPase signaling, linking it to the Rho-GAP BCR.

   Evidence Mouse knockout, subcellular fractionation and immunofluorescence, AMPA/NMDA EPSC recording, Co-IP/mass spectrometry from brain, and Rho GTPase activation assays

   PMID:29293918

   Open questions at the time

   • Direct functional role of the SESTD1–BCR complex not dissected
   • How SESTD1 coordinates Rac1 vs RhoA regulation unclear
   • Mechanism of pre- to postsynaptic shift unknown

• How SESTD1's Ca2+-dependent lipid binding mechanistically integrates with its regulation of Rho-family GTPases across channel, developmental, and synaptic settings remains unresolved.
• No structural model connecting lipid-binding and spectrin domains to GTPase regulation
• Whether a single biochemical activity unifies the TRPC, PCP, and synaptic roles is unknown
• No defined direct catalytic activity on GTPases